CVE-2026-94034

LOWCVSS 3.5/10

Last modified

CVE-2026-94034 is a low-severity vulnerability rated 3.5/10 on the CVSS scale. A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /drug_recommender/Admin/change_password of the component Password Change.

Description

A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /drug_recommender/Admin/change_password of the component Password Change. Performing a manipulation of the argument txtoldpassword/txtnewpassword results in cross site scripting. The attack can be initiated remotely. The exploit has been made public and could be used.

Metrics

Weakness Enumeration

Affected Software

Source: CNA advisory (CVE.org). NVD analysis pending.

VendorProductVersions
SourceCodesterDrug Recommendation System1.0

References

Timeline

Published
Last Modified
Status
Received

Frequently Asked Questions

What is CVE-2026-94034?
A vulnerability was found in SourceCodester Drug Recommendation System 1.0. This issue affects some unknown processing of the file /drug_recommender/Admin/change_password of the component Password Change. Performing a manipulation of the argument txtoldpassword/txtnewpassword results in cross site scripting. The attack can be initiated remotely. The exploit has been made public and could be used.
How severe is CVE-2026-94034?
CVE-2026-94034 has a CVSS score of 3.5/10 (LOW severity).
How do I fix CVE-2026-94034?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.

How Strix Helps

Related CVEs from 2026

Are you affected by CVE-2026-94034?

Run a free Strix scan to check your systems for this vulnerability.

Scan your code now

Source: NVD / NIST